Kim YH - Search Results

1

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Kim YH, et al. Arch Dermatol. 2003 Jul;139(7):857-66. doi: 10.1001/archderm.139.7.857. Arch Dermatol. 2003. PMID: 12873880

2

Bexarotene gel: a Food and Drug Administration-approved skin-directed therapy for early-stage cutaneous T-cell lymphoma.

Liu HL, Kim YH. Liu HL, et al. Among authors: kim yh. Arch Dermatol. 2002 Mar;138(3):398-9. doi: 10.1001/archderm.138.3.398. Arch Dermatol. 2002. PMID: 11902993 No abstract available.

3

Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.

Kim YH, Martinez G, Varghese A, Hoppe RT. Kim YH, et al. Arch Dermatol. 2003 Feb;139(2):165-73. doi: 10.1001/archderm.139.2.165. Arch Dermatol. 2003. PMID: 12588222

4

Gene expression profiles of cutaneous B cell lymphoma.

Storz MN, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. Storz MN, et al. Among authors: kim yh. J Invest Dermatol. 2003 May;120(5):865-70. doi: 10.1046/j.1523-1747.2003.12142.x. J Invest Dermatol. 2003. PMID: 12713594 Free article.

5

CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.

Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. Liu HL, et al. Among authors: kim yh. J Am Acad Dermatol. 2003 Dec;49(6):1049-58. doi: 10.1016/s0190-9622(03)02484-8. J Am Acad Dermatol. 2003. PMID: 14639383

6

Management with topical nitrogen mustard in mycosis fungoides.

Kim YH. Kim YH. Dermatol Ther. 2003;16(4):288-98. doi: 10.1111/j.1396-0296.2003.01640.x. Dermatol Ther. 2003. PMID: 14686971 Review.

7

Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.

Beynet DP, Wee SA, Horwitz SS, Kohler S, Horning S, Hoppe R, Kim YH. Beynet DP, et al. Among authors: kim yh. Arch Dermatol. 2004 Sep;140(9):1140-6. doi: 10.1001/archderm.140.9.1140. Arch Dermatol. 2004. PMID: 15381556

8

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.

Sundram U, Kim Y, Mraz-Gernhard S, Hoppe R, Natkunam Y, Kohler S. Sundram U, et al. J Cutan Pathol. 2005 Mar;32(3):227-34. doi: 10.1111/j.0303-6987.2005.00298.x. J Cutan Pathol. 2005. PMID: 15701085

9

Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.

Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, Chow S, Advani R, Warnke R, Kohler S, Hoppe RT, Kim YH. Tsai EY, et al. Among authors: kim yh. Arch Dermatol. 2006 May;142(5):577-84. doi: 10.1001/archderm.142.5.577. Arch Dermatol. 2006. PMID: 16702495

10

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Huang KP, et al. Among authors: kim yh. Arch Dermatol. 2007 Jan;143(1):45-50. doi: 10.1001/archderm.143.1.45. Arch Dermatol. 2007. PMID: 17224541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,849 results

Search Page

Filters